Insys Therapeutics Revenue and Competitors

Phoenix, AZ USA

Location

$2.3M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Insys Therapeutics's estimated annual revenue is currently $300M per year.(i)
  • Insys Therapeutics's estimated revenue per employee is $4,411,765
  • Insys Therapeutics's total funding is $2.3M.

Employee Data

  • Insys Therapeutics has 68 Employees.(i)
  • Insys Therapeutics grew their employee count by -1% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.2M366%N/AN/A
#2
$29.1M14548%N/AN/A
#3
$1.2M6-50%N/AN/A
#4
$1.4M717%N/AN/A
#5
$5.8M29-29%N/AN/A
#6
$33.2M16519%N/AN/A
#7
$41.8M20816%N/AN/A
#8
$3.6M18-36%N/AN/A
#9
$7M35-10%N/AN/A
#10
$11.7M58-11%N/AN/A
Add Company

We are a biopharmaceutical company focused on discovering, developing and commercializing innovative products to address chemotherapy-induced nausea and vomiting (CINV), pain management and other central nervous system disorders. We seek to apply new and proprietary formulations and delivery methods to existing pharmaceutical compounds in order to achieve enhanced efficacy, faster onset of action, reduced side effects, convenient delivery and increased patient compliance. Our drug development program is based on existing compounds with known safety, efficacy and commercialization histories. We believe this will increase the likelihood of success for our drug development and commercialization efforts. Our goal is to leverage our expertise in the expanding fields of synthetic cannabinoid derivatives and specialized opioid therapies to build a portfolio of proprietary products that address the limitations of existing treatments.

keywords:N/A

$2.3M

Total Funding

68

Number of Employees

$300M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Insys Therapeutics News

2022-04-20 - Cannabis-based Medicines Market Outlook 2022-2029| Key ...

Cannabis-based Medicines Market Outlook 2022-2029| Key Players – GW Pharmaceuticals plc, INSYS Therapeutics, Aequus Pharmaceuticals, Axim Biotechnologies.

2022-04-17 - Sublingual Sprays Market Forecast 2022-2030| Key Players ...

Insys Therapeutics; Sun Pharmaceutical; Mist Pharmaceuticals; Novadel Pharma; Generex Biotechnology; Gw Pharmaceutical; Europlaz Technologies And Piramal...

2022-04-17 - Cannabis Drug Market Size, Outlook And Forecast ...

Greenwich Biosciences, Abbive, Insys Therapeutics, Bausch Health, GW Pharmaceuticals, Unimed Pharmaceuticals, Indevus Pharmaceuticals, Pharmos.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.5M6826%N/A
#2
$18.8M681%N/A
#3
$3.5M6819%N/A
#4
$13M6911%N/A
#5
$16.8M691%N/A